Insider Transactions in Q3 2021 at Dia Medica Therapeutics Inc. (DMAC)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 15
2021
|
Harry W Alcorn Jr SVP, Clinical Operations |
BUY
Open market or private purchase
|
Direct |
15,000
+25.61%
|
$45,000
$3.8 P/Share
|
|
Aug 16
2021
|
Richard D. Pilnik Director |
BUY
Open market or private purchase
|
Direct |
15,000
+7.24%
|
$45,000
$3.25 P/Share
|
|
Aug 16
2021
|
Amy L. Burroughs Director |
BUY
Open market or private purchase
|
Direct |
44,950
+50.0%
|
$134,850
$3.15 P/Share
|
|
Aug 16
2021
|
Scott Kellen CFO and Secretary |
BUY
Open market or private purchase
|
Direct |
10,000
+30.97%
|
$30,000
$3.15 P/Share
|
|
Aug 16
2021
|
Dietrich John Pauls President and CEO |
BUY
Open market or private purchase
|
Direct |
5,000
+12.25%
|
$15,000
$3.14 P/Share
|
|
Aug 16
2021
|
Harry W Alcorn Jr SVP, Clinical Operations |
BUY
Open market or private purchase
|
Indirect |
399
+50.0%
|
$1,197
$3.07 P/Share
|
|
Aug 16
2021
|
Harry W Alcorn Jr SVP, Clinical Operations |
BUY
Open market or private purchase
|
Direct |
20,322
+21.28%
|
$60,966
$3.08 P/Share
|